Development of Highly Optimized Antibody–Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Puja Sapra|Clinical Cancer Research|2020Cited by 21
Supplementary Methods S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J. Zoeller, Puja Sapra|Unknown|2025Cited by 0